Trials / Completed
CompletedNCT02245503
Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,391 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objectives of this post marketing surveillance study were to document the comorbidity and comedication during prescription of ALNA® (Tamsulosin) for patients with BPH (Benign Prostatic Hyperplasia).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2003-10-01
- First posted
- 2014-09-19
- Last updated
- 2014-09-19
Source: ClinicalTrials.gov record NCT02245503. Inclusion in this directory is not an endorsement.